Harrell James Archie Jr 4
4 · Avalo Therapeutics, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Harrell James Archie Jr
Chief Commercial Officer
Transactions
- Purchase
Common Stock
[F1]2021-12-10$1.57/sh+1,093$1,716→ 36,766 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
Signature
/s/ Christopher R. Sullivan, by Power of Attorney|2021-12-14